Day, Wesley W
Vivus (United States)
4 papers on CoChatORCID 0000-0002-6451-8752
Most cited papers
- Verified
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Gadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 1,064
- Verified
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study
Garvey, W. T., Ryan, D. H., Look, M., Gadde, K. M., Allison, D. B., Peterson, C. A., Schwiers, M., Day, W. W., & Bowden, C. H. (2012) · The American Journal of Clinical Nutrition
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 716
- Verified
Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP)
Allison, D. B., Gadde, K. M., Garvey, W. T., Peterson, C. A., Schwiers, M. L., Najarian, T., Tam, P. Y., Troupin, B., & Day, W. W. (2012) · Obesity
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 711
- Verified
Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release
Garvey, W. T., Ryan, D. H., Henry, R., Bohannon, N. J. V., Toplak, H., Schwiers, M., Troupin, B., & Day, W. W. (2014) · Diabetes Care
Pharmacology and Obesity TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 215
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free